| Prev Close | 121.65 |
| Day Low/High | 121.51 / 123.57 |
| 52 Wk Low/High | 98.94 / 135.89 |
Medtronic Plc (MDT)
123.09
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1345.81B |
| Market Cap | 163.72B |
| P/E Ratio | 44.67 |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon
These companies were counted out way too early in the post-pandemic environment and the sellers are experiencing some real regret.
Surgical Device Maker Stryker Is Waiting to Move Higher
Let's review the charts and indicators.
Dissipating Fear, Too Much Cash, Elizabeth Warren, Software for Sale, Nvidia
The banks are parking large amounts of dough at the Fed every night. Last Friday's number was the highest single day total since 2017.
Costco Needs to Make a New High to Keep the Rally Going
The upcoming earnings report will also be an indicator.
Medtronic Remains on Track for Further Gains - Raise Stop Protection
Here's our longer-term price objective.
Night-Time Running and Trading, Tech Beatdown, Yellen on Bitcoin, My Nvidia Plan
Cryptos and cash are both headed for a real fight. For their own existence.
Market Themes, Yield Spreads, Treasury Auction, JNJ Vaccine, Trading Medtronic
If all goes well, JNJ could be able to immunize a billion individuals this year just by themselves.
Jim Cramer: Looking for Gold? Go With Science
A potential breakthrough in Alzheimer's. A new device for blood pressure. More vaccines. These are opportunities to cheer in a time of turmoil.
Medtronic Points Up, but Wait for More Strength to Buy
The technical indicators are mixed for the big medical device maker and suggest bulls are not strongly behind the latest advance in the shares.
Get Excited About This 'Boring' Trade
With Medtronic, momentum and trend are turning higher along with the breakout.
DexCom Could Work Itself Lower in the Weeks Ahead
A 'careful' approach is in order for traders.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Medical Device Maker Medtronic Could Weaken in the Weeks Ahead
MDT is set to report earnings on Tuesday.
Medtronic Has a Higher Target but the Near-Term Needs More Consolidation
I would look for some sideways to lower price action in the weeks ahead.
7 High-Tech Winners in Medical Diagnostics and Devices
These names combine healthcare research with state-of-the art technology.
Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?
Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'
Real Money Post Industrial Average Outperforms, Despite Outbreak
The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.
The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
Medtronic Stock Is in 'No Man's Land'
The medical device company is scheduled to report earnings this week.
Medtronic Presents an Opportunity, and Not Just Because It Makes Ventilators
The charts of the producer of medical equipment are holding up well, though its shares eventually could run into resistance.
Real Money Post Industrial Average Holds Own Amid Covid-19 Selloff
Amid a flood of corporate warnings over the coronavirus, all the major stock market indexes finished last month down 6.4% to 10.1%.
Jim Cramer: Rate Cut No Cure for Coronavirus
But don't throw up your arms yet -- here are names that could be golden opportunities.
Three Strategies for Income Investors
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
Does the Macro Matter for Equities? Salesforce Dreamforce Begins, Trading Apple
Tuesday's Dreamforce features a discussion between Salesforce's Marc Benioff and Apple's Tim Cook.
Medtronic Set to Trade Higher Unless Earnings Derail the Rally
Let's see what the charts have to say.
